Total Funding
$11.6M
Employee Range
1-10
Kimer Med is pioneering a range of broad-spectrum antiviral therapeutics, focusing initially on combatting the Dengue virus and enhancing pandemic preparedness. Having launched its Series A capital raise in September 2023, Kimer Med aims to revolutionize antiviral treatment and bolster global health resilience.
Kimer Med data powered by:
Share
Kimer Med data powered by:
Kimer MedOverall Ranking
National Rank
Share
Loading...
In New Zealand
Top null%out of startups
Regional Rank
Share
Loading...
In Australia and Oceania
Top null%out of startups
Kimer MedIndustry Rankings in
Healthtech
City Rank
Share
1st
In Nelson
Top 100%out of 1 startups
National Rank
Share
6th
In New Zealand
Top 15%out of 41 startups
Regional Rank
Share
73rd
In Australia and Oceania
Top 28%out of 270 startups
Kimer MedSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Nelson
Top 100%out of 1 startups
National Rank
Share
4th
In New Zealand
Top 24%out of 17 startups
Regional Rank
Share
20th
In Australia and Oceania
Top 27%out of 76 startups
rankings by:
Kimer MedSB Rank Evolution
Not enough data points to display the chart.
Kimer MedstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro